L. Wakefield, E. Piek, and E. Bottinger, TGF-beta signaling in mammary gland development and tumorigenesis, Journal of Mammary Gland Biology and Neoplasia, vol.6, issue.1, pp.67-82, 2001.
DOI : 10.1023/A:1009568532177

B. Bierie, A. Gorska, D. Stover, and H. Moses, TGF-?? promotes cell death and suppresses lactation during the second stage of mammary involution, Journal of Cellular Physiology, vol.13, issue.1, pp.57-68, 2009.
DOI : 10.1002/jcp.21646

E. Forrester, A. Chytil, B. Bierie, M. Aakre, A. Gorska et al., Effect of Conditional Knockout of the Type II TGF-?? Receptor Gene in Mammary Epithelia on Mammary Gland Development and Polyomavirus Middle T Antigen Induced Tumor Formation and Metastasis, Cancer Research, vol.65, issue.6, pp.2296-302, 2005.
DOI : 10.1158/0008-5472.CAN-04-3272

J. Massague, TGF?? in Cancer, Cell, vol.134, issue.2, pp.215-245, 2008.
DOI : 10.1016/j.cell.2008.07.001

L. Wakefield and A. Roberts, TGF-???? signaling: positive and negative effects on tumorigenesis, Current Opinion in Genetics & Development, vol.12, issue.1, pp.22-31, 2002.
DOI : 10.1016/S0959-437X(01)00259-3

B. Bierie and H. Moses, Tumour microenvironment: TGF??: the molecular Jekyll and Hyde of cancer, Nature Reviews Cancer, vol.274, issue.7, pp.506-526, 2006.
DOI : 10.1038/nrc1926

C. Heldin and A. Moustakas, Role of Smads in TGF?? signaling, Cell and Tissue Research, vol.282, issue.1, pp.21-36, 2012.
DOI : 10.1007/s00441-011-1190-x

A. Moustakas and C. Heldin, Non-Smad TGF-?? signals, Journal of Cell Science, vol.118, issue.16, pp.3573-84, 2005.
DOI : 10.1242/jcs.02554
URL : http://jcs.biologists.org/cgi/content/short/118/16/3573

J. Massague and Q. Xi, TGF-?? control of stem cell differentiation genes, FEBS Letters, vol.144, issue.14, pp.1953-1961, 2012.
DOI : 10.1016/j.febslet.2012.03.023

S. Dupont, M. Inui, and S. Newfeld, Regulation of TGF-?? signal transduction by mono- and deubiquitylation of Smads, FEBS Letters, vol.7, issue.14, pp.1913-1933, 2012.
DOI : 10.1016/j.febslet.2012.03.037

C. Hesling, L. Fattet, G. Teyre, D. Jury, G. P. Lopez et al., Antagonistic regulation of EMT by TIF1?? and Smad4 in mammary epithelial cells, EMBO reports, vol.12, issue.7, pp.665-72, 2011.
DOI : 10.1371/journal.pgen.1000575
URL : https://hal.archives-ouvertes.fr/hal-00835151

L. Fattet, A. Ay, B. Bonneau, L. Jallades, I. Mikaelian et al., TIF1?? requires sumoylation to exert its repressive activity on TGF?? signaling, Journal of Cell Science, vol.126, issue.16, pp.3713-3736, 2013.
DOI : 10.1242/jcs.126748

C. Hesling, J. Lopez, L. Fattet, P. Gonzalo, I. Treilleux et al., Tif1gamma is essential for the terminal differentiation of mammary alveolar epithelial cells and for lactation through SMAD4 inhibition. Dev (Cambridge England), pp.167-75, 2013.

D. Vincent, K. Yan, I. Treilleux, F. Gay, V. Arfi et al., Inactivation of TIF1?? Cooperates with KrasG12D to Induce Cystic Tumors of the Pancreas, PLoS Genetics, vol.46, issue.12, p.1000575, 2009.
DOI : 10.1371/journal.pgen.1000575.s005

R. Aucagne, N. Droin, J. Paggetti, B. Lagrange, A. Largeot et al., Transcription intermediary factor 1?? is a tumor suppressor in mouse and human chronic myelomonocytic leukemia, Journal of Clinical Investigation, vol.121, issue.6, pp.2361-70, 2011.
DOI : 10.1172/JCI45213DS1

B. Herquel, K. Ouararhni, K. Khetchoumian, M. Ignat, M. Teletin et al., Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma, Proceedings of the National Academy of Sciences, vol.108, issue.20, pp.8212-8219, 2011.
DOI : 10.1073/pnas.1101544108
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100982

S. Jain, S. Singhal, F. Francis, C. Hajdu, J. Wang et al., Association of overexpression of TIF1?? with colorectal carcinogenesis and advanced colorectal adenocarcinoma, World Journal of Gastroenterology, vol.17, issue.35, pp.3994-4000, 2011.
DOI : 10.3748/wjg.v17.i35.3994

C. Paiva, S. Drigo, F. Rosa, M. Neto, F. Caldeira et al., Absence of transforming growth factor-?? type II receptor is associated with poorer prognosis in HER2-negative breast tumours, Annals of Oncology, vol.21, issue.4, pp.734-774, 2010.
DOI : 10.1093/annonc/mdp518

C. Panis, A. Herrera, V. Victorino, A. Aranome, and R. Cecchini, Screening of circulating TGF-beta levels and its clinicopathological significance in human breast cancer, Anticancer Res, vol.33, issue.2, pp.737-779, 2013.

D. Koumoundourou, T. Kassimatis, V. Zolota, E. Tzorakoeleftherakis, P. Ravazoula et al., Prognostic significance of TGFbeta-1 and pSmad2/3 in breast cancer patients with T1?2, N0 tumours, Anticancer Res, vol.27, issue.4c, pp.2613-2633, 2007.

S. Desruisseau, J. Palmari, C. Giusti, R. S. Martin, P. Berthois et al., Determination of TGF??1 protein level in human primary breast cancers and its relationship with survival, British Journal of Cancer, vol.62, issue.2, pp.239-285, 2006.
DOI : 10.1053/gast.1996.v110.pm8566583

E. Richardsen, R. Uglehus, S. Johnsen, and L. Busund, Immunohistochemical expression of epithelial and stromal immunomodulatory signalling molecules is a prognostic indicator in breast cancer, BMC Research Notes, vol.5, issue.1, p.110, 2012.
DOI : 10.1183/09031936.98.12040811

L. Mcshane, D. Altman, W. Sauerbrei, S. Taube, M. Gion et al., REporting recommendations for tumor MARKer prognostic studies (REMARK), Breast Cancer Research and Treatment, vol.49, issue.2, pp.229-264, 2006.
DOI : 10.1007/s10549-006-9242-8

D. Allred, M. Bustamante, C. Daniel, H. Gaskill, C. Jr et al., Immunocytochemical Analysis of Estrogen Receptors in Human Breast Carcinomas, Archives of Surgery, vol.125, issue.1, pp.107-120, 1960.
DOI : 10.1001/archsurg.1990.01410130113018

E. P. Kaplan, Nonparametric Estimation from Incomplete Observations, Journal of the American Statistical Association, vol.37, issue.282, pp.457-81, 1958.
DOI : 10.1214/aoms/1177731566

D. Cox, Regression Models and Life-Tables, J R Stat Soc B, vol.34, issue.2, pp.187-220, 1972.
DOI : 10.1007/978-1-4612-4380-9_37

B. Bierie and H. Moses, Gain or loss of TGF-?? signaling in mammary carcinoma cells can promote metastasis, Cell Cycle, vol.8, issue.20, pp.3319-3346, 2009.
DOI : 10.4161/cc.8.20.9727

W. Xie, J. Mertens, D. Reiss, D. Rimm, R. Camp et al., Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study, Cancer Res, vol.62, issue.2, pp.497-505, 2002.

E. De-kruijf, T. Dekker, L. Hawinkels, H. Putter, V. Smit et al., The prognostic role of TGF-beta signaling pathway in breast cancer patients

Y. Kang, W. He, S. Tulley, G. Gupta, I. Serganova et al., Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway, Proceedings of the National Academy of Sciences, vol.102, issue.39, pp.13909-13923, 2005.
DOI : 10.1073/pnas.0506517102

M. Deckers, M. Van-dinther, J. Buijs, I. Que, C. Lowik et al., The Tumor Suppressor Smad4 Is Required for Transforming Growth Factor ??-Induced Epithelial to Mesenchymal Transition and Bone Metastasis of Breast Cancer Cells, Cancer Research, vol.66, issue.4, pp.2202-2211, 2006.
DOI : 10.1158/0008-5472.CAN-05-3560

G. Andrieux, L. Fattet, L. Borgne, M. Rimokh, R. Théret et al., Dynamic Regulation of Tgf-B Signaling by Tif1??: A Computational Approach, PLoS ONE, vol.45, issue.3, p.33761, 2012.
DOI : 10.1371/journal.pone.0033761.s007
URL : https://hal.archives-ouvertes.fr/hal-00851483

L. Hawinkels, T. Dijke, and P. , Exploring anti-TGF-?? therapies in cancer and fibrosis, Growth Factors, vol.32, issue.11, pp.140-52, 2011.
DOI : 10.1007/s10456-008-9101-9

E. Connolly, E. Saunier, D. Quigley, M. Luu, D. Sapio et al., Outgrowth of Drug-Resistant Carcinomas Expressing Markers of Tumor Aggression after Long-term T??RI/II Kinase Inhibition with LY2109761, Cancer Research, vol.71, issue.6, pp.2339-2388, 2011.
DOI : 10.1158/0008-5472.CAN-10-2941

C. Heldin, M. Vanlandewijck, and A. Moustakas, Regulation of EMT by TGF?? in cancer, FEBS Letters, vol.71, issue.14, pp.1959-70, 2012.
DOI : 10.1016/j.febslet.2012.02.037